Literature DB >> 2691160

Collagen induced arthritis: an experimental model for rheumatoid arthritis with involvement of both DTH and immune complex mediated mechanisms.

R Holmdahl1, J Mo, C Nordling, P Larsson, L Jansson, T Goldschmidt, M Andersson, L Klareskog.   

Abstract

The type II collagen induced arthritis animal model (CIA) provides opportunities to study the nature of autoimmune reactions leading to arthritis and is also a useful model for rheumatoid arthritis (RA). Thus, in similarity with RA, the CIA when induced with autologous type II collagen, shows a chronic and progressive disease course. The susceptibility to both RA and CIA are correlated to the expression of certain MHC class II allotype genes. In both diseases autoantibodies to type II collagen and rheumatoid factors are produced. Immunohistopathology of affected joints show in both diseases a dominance of activated macrophages/fibroblasts with a significant infiltration of activated T cells. We suggest here that both RA and CIA are dependent on a synergy between delayed type hypersensitivity and immune complex mediated inflammatory mechanisms and that CIA could provide a tool for studies of immunospecific reactions leading to arthritis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2691160

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  11 in total

Review 1.  Gene therapy for rheumatoid arthritis. Theoretical considerations.

Authors:  Y Chernajovsky; A Annenkov; C Herman; K Triantaphyllopoulos; D Gould; H Dreja; S P Moyes; J L Croxford; R A Mageed; O L Podhajcer; D Baker
Journal:  Drugs Aging       Date:  1998-01       Impact factor: 3.923

Review 2.  Adhesion molecules in inflammatory diseases: insights from knockout mice.

Authors:  Daniel C Bullard
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

3.  Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells.

Authors:  M Gray; K Miles; D Salter; D Gray; J Savill
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-21       Impact factor: 11.205

4.  The destruction evaluation in different foot joints: new ideas in collagen-induced arthritis rat model.

Authors:  Peng Zhang; Dong Han; Tingting Tang; Xiaoling Zhang; Kerong Dai
Journal:  Rheumatol Int       Date:  2008-11-04       Impact factor: 2.631

5.  Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis.

Authors:  R O Williams; L J Mason; M Feldmann; R N Maini
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

6.  B Cell in Autoimmune Diseases.

Authors:  Christiane S Hampe
Journal:  Scientifica (Cairo)       Date:  2012

7.  A Novel Triazolopyridine-Based Spleen Tyrosine Kinase Inhibitor That Arrests Joint Inflammation.

Authors:  Gregory D Ferguson; Mercedes Delgado; Veronique Plantevin-Krenitsky; Kristen Jensen-Pergakes; R J Bates; Sanaa Torres; Maria Celeridad; Heather Brown; Kelven Burnett; Lisa Nadolny; Lida Tehrani; Garrick Packard; Barbra Pagarigan; Jason Haelewyn; Trish Nguyen; Li Xu; Yang Tang; Matthew Hickman; Frans Baculi; Steven Pierce; Keiji Miyazawa; Pilgrim Jackson; Philip Chamberlain; Laurie LeBrun; Weilin Xie; Brydon Bennett; Kate Blease
Journal:  PLoS One       Date:  2016-01-12       Impact factor: 3.240

Review 8.  The Urokinase Plasminogen Activation System in Rheumatoid Arthritis: Pathophysiological Roles and Prospective Therapeutic Targets.

Authors:  Benjamin J Buckley; Umar Ali; Michael J Kelso; Marie Ranson
Journal:  Curr Drug Targets       Date:  2019       Impact factor: 3.465

9.  Evaluation of Artemisia amygdalina D. for Anti-Inflammatory and Immunomodulatory Potential.

Authors:  Khan Mubashir; Bashir A Ganai; Khalid Ghazanfar; Seema Akbar; Akhtar H Malik; Akbar Masood
Journal:  ISRN Inflamm       Date:  2013-10-10

Review 10.  Animal Models of Bone Loss in Inflammatory Arthritis: from Cytokines in the Bench to Novel Treatments for Bone Loss in the Bedside-a Comprehensive Review.

Authors:  C Henrique Alves; Eric Farrell; Marijn Vis; Edgar M Colin; Erik Lubberts
Journal:  Clin Rev Allergy Immunol       Date:  2016-08       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.